(AWARD)Review of work-based violence, harassment and abuse in the NHS and impact of the safety and wellbeing of our people - on behalf of NHS England / NHS Improvement

Award

Value

£250,000

Classifications

  • Research and development services and related consultancy services

Tags

  • award
  • contract

Published

2 years ago

Description

Background
The NHS People Plan 2020/21 was published in July, with a strong emphasis on 'Looking after our People' - including 23 commitments related to health and wellbeing. One of the NHS People Plan Promise's is that all our people feel supported, safe and secure at work.
"The safety and health of our people is paramount. Leaders across the NHS have a statutory duty of care to prevent and control violence in the workplace - in line with existing legislation - so that people never feel fearful or apprehensive about coming to work."
There is overwhelming evidence regarding the impact that violence, harassment and abuse can have on people's health and wellbeing, affecting mental and physical health. In the most tragic cases, this can result in loss of life or life-changing injuries and psychological issues. For others, it can lead to increased stress and anxiety levels, reduced confidence and resilience, and an impact on their families.
Research shows that staff who experience violence and aggression at work are four times more likely to take sick leave and are more inclined to leave the NHS. The pandemic has arguably compounded the risks of traumatisation for many people, including health care leaders and their teams. There is also an increasing body of evidence highlighting the impact
violence and abuse has on patient care.
Since NHS Protect was disbanded in 2016 there has been no national NHS wide data collection of incidents relating to violence, harassment and abuse against our NHS colleagues. The only sector that has continued to collect and report on an annual basis is the ambulance service.
Incident data is, however, still collected individually by Trusts but there is no mechanism currently to view and assess the data at a regional or national level to inform future planning, commissioning, and future interventions. A small scale incident data collection exercise conducted in 2021 examining local data held by a number of Trusts highlighted many inconsistencies and gaps around recording and naming conventions in relation to the reporting of incidents of violence, harassment and abuse in the workplace and potential causation factors.
The COVID pandemic has further heightened concerns around violence, harassment and abuse to staff in the workplace and a number of professional representative groups, associations and unions have been undertaking their own surveys and analysis to inform organisational responses. To date the findings from all these studies have not been brought together to be reviewed and assessed to understand the impact, nature and causation, where known, of violence, harassment and abuse against our colleagues.
2. Aim and Objectives of the review 2.1 Aim
The aim of the project is to better understand the nature, extent and impact of work-based violence, harassment and abuse to NHS staff across all healthcare settings, while identifying good practice in preventative approaches and responses that can inform future interventions.

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

  • Contract Agreement

    The official contract terms, conditions, and scopes of work.

    Download
  • Award Notice

    Details on the tender award and selected suppliers.

    Download

Similar Contracts

Open

NICE External Assessment Groups Framework

NICE is seeking to commission external assessment groups (EAGs) which will provide a range of services to support its programmes and related activities. Suppliers can bid for one or more Lots. NICE will consider bids from multidisciplinary EAGs with knowledge and expertise in health technology assessment. NICE will consider proposals from consortia or networks of organisations meeting the selection criteria and encourages potential suppliers to explore collaborations that will result in the offer of a comprehensive range of services. Main activities of the EAGs in each framework NICE commissions EAGs to support its guidance development programmes in the following key areas and tasks: Lot 1 - Clinical and Economic Evidence Assessment Including: critical appraisal of clinical and economic evidence to support the development of NICE outputs; evidence synthesis; de novo economic modelling and critiquing and revising existing models; systematic review and meta-analysis; supporting scoping of evaluation topics; user preference assessment or structured elicitation, confirmation and review of regulatory status to the evaluation programmes. Lot 2 - Technical and Decision Support Including: providing advanced methodological and analytical advice and support to NICE's technical teams and committees on all guideline and technology types that are in remit for NICE, including Health Technology Evaluation (HTE) outputs (pharmaceuticals, diagnostics, medical device and digital technologies, combination products etc.) and Guidelines topics covering public health, social and clinical areas. This includes providing evidence synthesis, data analytics, complex decision analytical modelling and health economic support; providing a technical rapid response service and quality assurance input for guidance products; development and provision of guidance methods training, covering evidence synthesis, data analytics, decision analytical modelling and health economics. Lot 3 - Evidence Generation to support Access Including: Evidence generation using existing registers or databases, feasibility studies, data protocol development, pilot studies; data collection and active surveillance; data linkage and complex modelling and/or analyses; register set up and close. Lot 4 Research governance & ethics support Including: advice on research governance and ethics support including access to a research ethics committee.

Open

NICE External Assessment Groups Framework

NICE is seeking to commission external assessment groups (EAGs) which will provide a range of services to support its programmes and related activities. Suppliers can bid for one or more Lots. NICE will consider bids from multidisciplinary EAGs with knowledge and expertise in health technology assessment. NICE will consider proposals from consortia or networks of organisations meeting the selection criteria and encourages potential suppliers to explore collaborations that will result in the offer of a comprehensive range of services. Main activities of the EAGs in each framework NICE commissions EAGs to support its guidance development programmes in the following key areas and tasks: Lot 1 - Clinical and Economic Evidence Assessment Including: critical appraisal of clinical and economic evidence to support the development of NICE outputs; evidence synthesis; de novo economic modelling and critiquing and revising existing models; systematic review and meta-analysis; supporting scoping of evaluation topics; user preference assessment or structured elicitation, confirmation and review of regulatory status to the evaluation programmes. Lot 2 - Technical and Decision Support Including: providing advanced methodological and analytical advice and support to NICE's technical teams and committees on all guideline and technology types that are in remit for NICE, including Health Technology Evaluation (HTE) outputs (pharmaceuticals, diagnostics, medical device and digital technologies, combination products etc.) and Guidelines topics covering public health, social and clinical areas. This includes providing evidence synthesis, data analytics, complex decision analytical modelling and health economic support; providing a technical rapid response service and quality assurance input for guidance products; development and provision of guidance methods training, covering evidence synthesis, data analytics, decision analytical modelling and health economics. Lot 3 - Evidence Generation to support Access Including: Evidence generation using existing registers or databases, feasibility studies, data protocol development, pilot studies; data collection and active surveillance; data linkage and complex modelling and/or analyses; register set up and close. Lot 4 Research governance & ethics support Including: advice on research governance and ethics support including access to a research ethics committee.

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Timeline complete

Publish
Bid
Evaluate
Award
Complete